RxDoctor Payments Data

Justin Legris, MD

Family Medicine · Nixa, MONPI 1952715716

Payments from drug & device makers

$867in general payments, 2019–2025

Across 43 payments — averaging $20.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$207
  • AstraZeneca$112
  • Novo Nordisk$91
  • Abiomed$76
  • AbbVie$69
  • Exact Sciences$66
  • plus $247 from 9 others

What the payments were for

  • Food & beverage$867100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$867 in reported general payments places this provider in the 60th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$47,489
Medicare patients
174
Services billed
738

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban91$64,095
TrulicityDulaglutide42$51,363
JardianceEmpagliflozin49$37,091
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$36,010
OzempicSemaglutide16$27,318
MounjaroTirzepatide17$21,871
FarxigaDapagliflozin Propanediol26$13,470
ElmironPentosan Polysulfate Sodium12$12,408
MyrbetriqMirabegron19$10,554
Combivent RespimatIpratropium/Albuterol Sulfate17$9,015
Breo ElliptaFluticasone/Vilanterol14$7,064
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen291$6,961
SymbicortBudesonide/Formoterol Fumarate25$6,804
ShingrixVaricella-Zoster Ge/As01b/Pf28$6,162
Lantus SolostarInsulin Glargine,hum.Rec.Anlog43$5,014

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$207$67,302102 claims
Novo NordiskOzempic$91$27,31816 claims
AstraZenecaFarxiga, Symbicort$112$20,27451 claims
Astellas Pharma US IncMyrbetriq$23$10,55419 claims
AbbVieSynthroid$69$2,26127 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Nixa

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →